Two momentum growth stocks that could help you retire wealthy

Here are two tasty growth shares that could keep on climbing.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in software company Kainos (LSE: KNOS) had a shaky first year after flotation, getting an EU referendum-linked hammering last June. But since then, momentum has been picking up and the price has soared by 85% in less than a year, to 230p — even after a 4% drop on results day Tuesday.

The response to the results looks like a common event — a high-flying growth company reports some unexciting figures, and the price drops. Are people right to be selling today, or are we looking at a buying opportunity?

Analysts did have a fall in earnings per share of 12% pencilled-in, and the actual figures depend on how you look at them — there was a reported 18% fall, which is worse than that, but adjusted EPS fell by only 10%, which was better.

Either way, it seems like a short-term trifle to me. The provider of digital services and platforms reported a 9% rise in revenues and analysts are predicting a return to EPS growth for the coming year, with it accelerating the year after. 

Global growth

Chief executive Brendan Mooney spoke of “strong growth in Digital Services, driven by demand from existing customers, new customer acquisition and geographic expansion,” and reckoned the firm is “well-positioned for growth in the coming years.

This year’s earnings blip is at least partly down to “the funding challenge in the NHS,” but Kainos is expanding its global operations — a new office in Frankfurt brings its tally of European and US offices up to eight. And after the financial year ended, a new contract has seen the firm providing services to 38 US hospitals.

There’s a dividend too, up 5% and ahead of expectations, for a modest 2.7% yield — but it’s looking nicely progressive.

A Woodford punt?

One thing you can definitely say about Neil Woodford is that he’s not afraid of taking a blue-sky risk on companies that are not yet profitable — especially in the healthcare and biotechnology field. Horizon Discovery (LSE: HZD) is one, and though it only accounts for a tiny portion of his CF Woodford Equity Income Fund, he holds a number of similar picks.

I reckon Mr Woodford’s approach to blue-sky growth is sensible. It’s a very high risk strategy, and having a basket of different stocks should greatly improve your safety — and, after all, you really only need one or two to come good.

Horizon is into the very exciting field of therapeutic gene editing, and this month told us it “has gained exclusive worldwide rights to use a novel transposon-based technology platform that will broaden Horizon’s gene editing capabilities,” which was co-invented by its own head of innovation. It’s mainly funded by downstream royalty payments, so shouldn’t impact the cash position too much in the short term.

Jam soon?

Full-year results released Tuesday revealed a 19% rise in revenue to £24.1m, including a 45% rise in product revenue to £11.3m, and a gross margin boosted to 54%. So while there’s no profit yet (and none forecast for the next two years — though losses per share should be getting close to break-even before too long), I think these figures do provide appealing promise of profits within the next few years.

There are no meaningful fundamental ratios here, but if you’re prepared to take a bit of a punt, I see Horizon as having attractive potential.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

FTSE shares in 2025: an opportunity to get rich?

The FTSE hasn’t universally satisfied investors in recent years, but there are certainly enticing opportunities on the index in 2025.

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

2025: a great opportunity for investors to get rich and work towards a second income?

To earn a second income from investing, we typically need a good pot of money. Dr James Fox explores where…

Read more »

Bearded man writing on notepad in front of computer
Investing Articles

£20k to invest for a decade? These exchange-traded funds (ETFs) could turn that into almost £100k!

Exchange-traded funds (ETFs) can deliver spectacular long-term returns, as these US- and UK-listed vehicles have already shown.

Read more »

Dividend Shares

2 infrastructure dividend shares with yields of 7% or higher

Jon Smith outlines two dividend shares from a sector that boasts high yields at the moment -- but there are…

Read more »

Investing Articles

2 FTSE 100 growth shares that could shine in 2025

Paul Summers picks out two FTSE 100 growth shares that, despite performing very differently in 2024, he thinks could end…

Read more »

Investing Articles

My top 2 stock market predictions for 2025

This writer didn’t receive a crystal ball for Christmas, but he still has a couple of stock market predictions for…

Read more »

Investing Articles

3 companies that could emulate Nvidia stock’s success in 2025

Nvidia stock has generated market topping growth over the past two years. But investors need to be asking themselves, who…

Read more »

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

Here’s my plan for maximising the returns from my Stocks and Shares ISA in 2025

After a good 2024, Stephen Wright has two key ideas he wants to implement in his Stocks and Shares ISA…

Read more »